Columbia Research Enhanced Value ETF (REVS)

Assets	$219.14M
Expense Ratio	0.19%
PE Ratio	18.03
Shares Out	7.40M
Dividend (ttm)	$0.60
Dividend Yield	2.05%
Ex-Dividend Date	Dec 18, 2025
Payout Frequency	Annual
Payout Ratio	37.06%

Volume	26,939
Open	29.43
Previous Close	29.66
Day's Range	29.14 - 29.53
52-Week Low	21.79
52-Week High	30.17
Beta	0.82
Holdings	314
Inception Date	Sep 25, 2019

About REVS

Fund Home Page

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is issued by Columbia Threadneedle.

• Asset Class: Equity
• Category: Large Value
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: REVS
• ETF Provider: Columbia Threadneedle
• Index Tracked: Beta Advantage Research Enhanced US Value Index

Top 10 Holdings

26.53% of assets

Name	Symbol	Weight
The Procter & Gamble Company	PG	3.72%
Exxon Mobil Corporation	XOM	3.55%
Wells Fargo & Company	WFC	3.44%
Cisco Systems, Inc.	CSCO	2.69%
Alphabet Inc.	GOOGL	2.66%
Pfizer Inc.	PFE	2.29%
Alphabet Inc.	GOOG	2.17%
Citigroup Inc.	C	2.12%
Chevron Corporation	CVX	1.96%
The Charles Schwab Corporation	SCHW	1.93%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$0.60215	Dec 26, 2025
Dec 18, 2024	$0.46667	Dec 26, 2024
Dec 18, 2023	$0.53855	Dec 26, 2023
Dec 19, 2022	$0.48105	Dec 27, 2022
Dec 20, 2021	$0.25246	Dec 27, 2021
Dec 18, 2020	$4.66911	Dec 28, 2020

Performance

REVS had a total return of 18.68% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.09%.